Abbott stock price dips again after earnings shock as analysts trim targets
Abbott shares fell 1.1% to $107.42 in after-hours trading Friday, extending losses after the company forecast first-quarter profit below Wall Street estimates and missed revenue targets. CEO Robert Ford cited higher manufacturing costs and weaker nutrition demand. Wells Fargo cut its price target, citing headwinds in nutrition and diagnostics. Abbott reported Q4 sales up 4.4% to $11.46 billion and raised device sales 12.3%.